24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Diabetes
Resources
Basic InformationLatest News
Have Diabetes? Don't Lose Sight of Danger to Your EyesCommon Diabetes Meds Linked to Higher Odds for a Serious ComplicationAHA News: Controlling Diabetes Takes on Greater Urgency During COVID-19 PandemicStressful Days, Worse Blood Sugar Control for People With DiabetesAnimal Tests Point to Possible Path to Ultrafast InsulinSigns of Developing Adult Diabetes Seen as Early as Age 8: StudyDoes COVID-19 Trigger New Cases of Diabetes?Telehealth Programs Improve Blood Sugar for Rural Americans With DiabetesContinuous Glucose Monitors Help With Type 1 Diabetes at Any AgeCost of Type 1 Diabetes: $2,500 a Year With Insurance1 in 10 Hospitalized COVID-19 Patients With Diabetes Dies: StudyWhite House Announces Plan for Medicare Recipients to Get Insulin at $35 Per MonthLost Pregnancies, Diabetes May Be LinkedType 2 Diabetes Linked to Worse Mental Outcomes After StrokeSleep Apnea Tied to Raised Diabetes Risk in Black AmericansHeart Attacks, Strokes Are Declining Among People With DiabetesCould Your Contact Lenses Track, Treat Your Diabetes?AHA News: Managing Diabetes Risk in Hispanic, Asian CommunitiesObesity Is Biggest Type 2 Diabetes Risk FactorAHA News: Understanding the Risky Combination of Diabetes and the CoronavirusWhy Is Coronavirus a Bigger Worry for People With Diabetes?What People With Type 1 Diabetes Need to Know About COVID-19Family Ties Help Young Adults With Type 1 Diabetes FlourishPatch Pump Device Could Offer Cheaper Insulin DeliveryCan AI Predict Who Will Develop Diabetes?Blood Sugar Control May Aid Stroke Recovery in Diabetes PatientsBacteria May Be a Player in Diabetes Among Very ObeseNew Tool Helps Muslims With Diabetes Manage Blood Sugar During Ramadan FastWant to Help Keep Diabetes at Bay? Brush & FlossDiabetes Among U.S. Young, Especially Asians, Continues to ClimbDrug Duo Speeds Regeneration of Key Cells Lost in DiabetesMedicare Could Save Billions If Allowed to Negotiate Insulin PricesAt the Barbershop, a Trim -- and a Diabetes ScreeningCertain Diabetes Meds May Lower Gout Risk, TooBig Advances Made Against Diabetes in 2019CDC Study Breaks Down Diabetes Risk for Hispanic, Asian SubgroupsFDA Authorizes Marketing of Automated Insulin Dosing ControllerDo Processed Foods Up Your Type 2 Diabetes Risk?Changing Timing, Frequency of Meals May Help With Diabetes'Diabetes Burnout' Is Real, Here's How to CopeAs Diabetes Costs Soar, Many Turn to Black Market for HelpFDA Testing Levels of Carcinogen in Diabetes Drug MetforminMom-to-Be's Diabetes May Up Odds of Heart Disease in Her KidsPrediabetes Now Common Among Teens, Young AdultsHeart Attack at 44 Helped Her Realize Diabetes' DangersDiabetes Tougher on Women's HeartsDiabetes Technology Often Priced Out of ReachSupplements Don't Prevent Kidney Disease in Type 2 DiabeticsWhy Are Insulin Prices Still So High for U.S. Patients?Health Tip: Snacks for People With Diabetes
Links
Related Topics

Medical Disorders

Could Your Contact Lenses Track, Treat Your Diabetes?

HealthDay News
by By Serena Gordon
HealthDay Reporter
Updated: Apr 24th 2020

new article illustration

FRIDAY, April 24, 2020 (HealthDay News) -- Contact lenses may someday do more than correct poor vision, with new, preliminary research in animals suggesting they could also monitor your diabetes and deliver medications.

The new lenses were designed to check blood sugar levels and to deliver drugs to the eye, possibly for the eye disease related to diabetes called diabetic retinopathy. After trying them out on rabbits, scientists found the new lenses worked on both counts.

It may sound like science fiction, but the researchers noted there is already a contact lens that's been approved by the U.S. Food and Drug Administration for measuring the pressure in the eye when worn overnight. Levels of eye pressure are important to know for people with the eye disease glaucoma.

"Among various wearable devices, a smart contact lens is especially promising for health care applications because it can be used as an excellent interface between the human body and an electronic device," said senior study author Sei Kwang Hahn. He's a professor at Pohang University of Science and Technology in South Korea, and a visiting professor at Stanford University in California.

Hahn said this is the first study to show a combination of blood sugar sensing and drug delivery technology in a contact lens. However, what works well in animals doesn't always work well in humans.

The smart contact lens contains ultrathin, flexible electrical circuits and a microcontroller chip. It's currently about 0.2 millimeters (mm) thick, and Hahn said the researchers hope to reduce that to 0.15 mm. Hahn said the current lens is already thinner than the FDA-approved lenses that measure eye pressure.

Dr. John Hovanesian, a clinical spokesperson for the American Academy of Ophthalmology, said the lens would likely be comfortable enough for people to wear, but it is significantly thicker than a standard contact lens.

Chemicals on the contact lens bind with glucose and trigger an electrical current change that is proportional to the amount of glucose. The electric current is also used to dissolve gold membranes that seal drug reservoirs, triggering the release of a dose of the drug, Hahn explained.

"This study is ambitious and bold. They're trying a moonshot. But, I would be cautious in my expectations," Hovanesian said.

"One of the biggest challenges to monitoring glucose in the eye with contacts is that you have to be cautious about the use of contact lenses in people with diabetes because infections and injuries can become more serious," he noted.

Still, he added, "there are a lot of exciting possibilities with this."

One big possibility is the potential to deliver drugs that are commonly used to treat diabetic retinopathy via the contact lens. Those drugs are currently delivered via injections to the eye.

In this study, the researchers used a drug called genistein, which isn't approved by the FDA in the United States.

Sanjoy Dutta, vice president of research at JDRF (formerly the Juvenile Diabetes Research Foundation), said, "They've done good preliminary preclinical work. Looking forward, we need to know how accurate is tear glucose compared to blood glucose. And, the Achilles' heel may be in connecting the two components (glucose sensing and drug delivery)."

Dutta said that there are a number of research projects looking at ways to measure glucose levels without having to draw blood or wear a continuous glucose monitor. Some other options that have been tried or are being tried are monitoring through sweat, tears, saliva and infrared light.

"Any non-blood-based glucose monitoring is very challenging," Dutta noted.

Hahn and his team are hoping to begin human clinical trials in 2021. If those go well, their hope is to have a commercial product as soon as 2023.

The findings were published April 24 in the journal Science Advances.

More information

Learn more about diabetic retinopathy treatment from the American Academy of Ophthalmology.